Combustible cigarettes are losing market share to three alternatives simultaneously. Heated tobacco products, e-cigarettes, and nicotine pouches each deliver nicotine through a completely different mechanism. For manufacturers and ingredient suppliers, this fragmentation is the defining reality of the modern nicotine industry.
One supplier portfolio. Three different product specs. Three different regulatory regimes.
Heated Tobacco: Combustion's Nearest Neighbor
Heated tobacco products (HTPs) use specially designed tobacco sticks heated to 250-350 degrees C. That is well below the 600-900 degrees C where combustion happens in a traditional cigarette. The result: nicotine and flavor release without tar and many of the harmful compounds combustion generates.
The major players:
- IQOS (Philip Morris International). Market leader. Blade-based heating system with HEETS tobacco sticks.
- glo (BAT). Induction heating with Neostiks.
- Ploom (JTI). Redesigned induction heating platform.
Where nicotine suppliers fit: HTPs primarily use processed tobacco, not extracted nicotine. But that is changing. Next-generation HTP designs increasingly use nicotine-enriched substrates and reconstituted tobacco sheets with added nicotine to hit target delivery levels. This is a growing segment for extracted nicotine suppliers.
Vaping: The Extracted Nicotine Market
Vaping devices heat e-liquid (nicotine dissolved in VG/PG carriers with flavorings) into an inhalable aerosol. No tobacco leaf involved. The nicotine is extracted, purified, and dissolved.
Three hardware segments, three trajectories:
- Open systems (refillable tanks and mods). Declining in some markets due to regulation.
- Closed systems/pods (JUUL, VUSE, etc.). The dominant format in regulated markets.
- Disposables. Fastest growing, but facing regulatory crackdowns globally.
Nicotine requirements are specific. E-liquid manufacturing needs high-purity extracted nicotine in precise forms:
- Freebase nicotine at USP/EP grade (99.5%+ purity) for traditional e-liquids
- Nicotine salts (benzoate, lactate, or other salt forms) for pod systems and higher-concentration formulations
- Pre-mixed nicotine dilutions in VG/PG carriers, typically at 100 mg/mL
The carrier choice alone changes your production process, flavor profile, and target device compatibility. VG-based dilutions produce different results than PG-based ones, and most manufacturers need both.
Nicotine Pouches: The Fastest Segment
No heating element. No liquid. No tobacco leaf. Just a small white pouch between the lip and gum delivering nicotine through oral mucosal absorption.
The global pouch market is projected to reach $35 billion by 2028. Consumers want discreet, smoke-free, spit-free nicotine. Regulators are more receptive to a product with no combustion and no tobacco.
Nicotine requirements are different again:
- Nicotine bitartrate dihydrate. The dominant form. Solid, stable, water-soluble, precise milligram dosing.
- Nicotine polacrilex. For controlled-release applications.
- Freebase nicotine. Used in some higher-strength formulations.
Three Formats, One Supply Chain Problem
Here is what the fragmentation means in practice:
Product portfolio breadth
A decade ago, most nicotine demand was for e-liquid. Today, a supplier needs to serve e-liquid manufacturers, pouch producers, pharmaceutical NRT companies, and increasingly HTP customers. Each one has different product specs. Different concentration requirements. Different documentation standards.
Ask yourself: can your current supplier serve all of your product lines? Or are you managing multiple supplier relationships because no single source covers your portfolio?
Quality is converging upward
Even non-pharmaceutical products now routinely require pharmacopoeial-grade nicotine. This is not manufacturers being cautious. It is regulators and retail buyers raising the floor. The gap between "pharmaceutical grade" and "everything else" is closing because everything else is being pulled up to pharmaceutical standards.
Regulatory complexity multiplies
HTPs face tobacco product regulation. Vapes face TPD in Europe, PMTA in the US, and varying frameworks elsewhere. Pouches face novel food regulations in some markets and tobacco-adjacent regulation in others. Your nicotine supplier needs to understand these distinctions because the documentation they provide feeds directly into your regulatory filings.
New forms, new opportunity
The evolution is not over. Novel nicotine salts, encapsulated nicotine, slow-release formulations, and nicotine-enriched substrates are all in active development. Manufacturers with supplier relationships that include R&D collaboration will move faster than those treating nicotine as a commodity purchase.
Where NicAlliance Fits
NicAlliance supplies pure nicotine, nicotine salts, nicotine bitartrate dihydrate, nicotine polacrilex, and nicotine dilutions across every delivery platform. One supplier. Full documentation. STC traceability from field to your facility. Whether you are formulating e-liquids, manufacturing pouches, or developing next-generation heated products, the ingredient quality and regulatory paperwork come from the same source.
If this was useful, there's more where it came from.
Industry intelligence for nicotine product manufacturers. No fluff.